Business

Introduction to
Bioaccell Inc.'s Businesses

Bioaccell Inc. based in Katsura Venture Plaza, Kyoto University, are engaged in the business of supporting the cultivation and processing of therapeutic immune cells for malignant tumors for medical institutions.

What is Immuno Cell Therapy?

“Activate the patient's own Immune Cells”

Immuno Cell Therapy is an advanced treatment that uses the patient’s own immune cells to attack cancer using “the power to heal itself”.

It is believed that cancer cells are constantly being generated in our bodies, even in healthy people. However, they do not immediately become cancerous because there are also immune cells that attack cancer cells. When the balance between cancer cells and immune cells is disturbed for various reasons and the proliferation of cancer cells exceeds that of immune cells, a disease called cancer occurs.

Therefore, cancer immune cell therapy is an approach to suppress cancer cells by artificially multiplying immune cells from the patient’s own blood and reinforcing their function.

Bioaccell Inc. is engaged in the cultivation and processing of therapeutic immune cells used in cancer Immuno Cell Therapy.

Based on advanced and highly safe culture technology,
We provide regenerative cell medicine.

Providing “world-class” Dendritic Cell
activation technology

We offer a DC vaccine that is highly versatile and can effectively induce CTLs in many types of tumors.

Aiming for the latest and the best
- Emphasis on basic research -

We believe that steady basic research is essential in order to provide the latest and best cell culture technology from the laboratory to the medical field.

“Highly effective, Low cost of care.”

~To achieve reasonable treatment costs~.

Immuno Cell Therapy as an unrestricted treatment is not covered by health insurance, resulting in high treatment costs.

We are committed to achieving reasonable processing costs in order to lighten the financial burden on many patients.

Our goal is to accelerate the spread of this therapy by providing regenerative cells with reasonable processing costs that do not compromise safety, minimize costs, and ensure quality, with the aim of making immuno-cell therapy a treatment that everyone can receive.

Bioaccell's CPF
(Cell Processing Factory)

CPF (Cell Processing Factory) is managed by a 24-hour computer system to maintain a cleanliness level of Class 10,000 (Class 100 and ISO Class 5 in the work area) at all times. Safety is also emphasized through a double-check system.

We have a system that allows us to inspect cultured cells for endotoxin, mycoplasma, etc. in-house.

Licensed by the Kinki Bureau of Health and Welfare for the manufacture of specific cell-processed products
Facility No. FA5190003

We disseminate correct knowledge about cancer to the world.

Our CEO, Shigeru Hirabayashi, is a science writer and has published many books on cancer Immuno Cell Therapy.

Bioaccell faces the disease of cancer and cancer immuno-cell therapy more than any other company. Because we know cancer, we can do what we can do.

We value the true voice of our patients

Cancer Patients Association
“Fir Tree”

Shigeru Hirabayashi, President of Bioaccell, has been the president of a cancer patient group called “Fir Tree” for many years. Bioaccell is not only looking at technological development, but is also facing the real feelings of patients and working together with them to face up to the disease of cancer.

Bioaccell Inc. was founded by the Patients Association based on the voices of patients.